RhumbLine Advisers’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

RhumbLine Advisers’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-100,491	Closed	-$2.42M	–	3015
2014 Q2	$2.42M	Buy	100,491 +20,389	+25%	+$213K	0.01%	1248
2014 Q1	$483K	Sell	80,102 -700	-0.9%	-$4.88K	﹤0.01%	2255
2013 Q4	$483K	Sell	80,802 -2,330	-3%	-$10.8K	﹤0.01%	2279
2013 Q3	$433K	Sell	83,132 -10,511	-11%	-$46.1K	﹤0.01%	2311
2013 Q2	$338K	Buy	+93,643	New	+$383K	﹤0.01%	2551

RhumbLine Advisers's IDIX Position: Q3 2014 in Review

RhumbLine Advisers sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 100,491 shares — an estimated $2.42M sold.

RhumbLine Advisers first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $2.42M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

RhumbLine Advisers reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
RhumbLine Advisers sold 100,491 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.42M.
RhumbLine Advisers first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
RhumbLine Advisers's IDENIX PHARMACEUTICALS INC position peaked at $2.42M in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.